President Donald Trump’ s senior advisers are expected to meet with Ukrainian President Volodymyr Zelenskyy this week on the ...

Surging up the cornerback room is near the top of the Minnesota Vikings' off-season needs. With Byron Murphy, Stephon Gilmore, and Shaquill Griffin all slated to be free agents this off-season ...

Discussions on the Minnesota Vikings’ quarterback room have largely revolved around what will happen with Sam Darnold. However, J.J. McCarthy’s progression will be a driving factor in the ...

From left to right, Vikings owner Zygi Wilf, coach Kevin O'Connell, first-round draft picks J.J. McCarthy and Dallas Turner, General Manager Kwesi Adofo-Mensah and owner Mark Wilf. (Abbie Parr/The ...

The Minnesota Vikings have a long list of players to replace ahead of free agency. Of the Vikings' 2024 roster, 19 pending free agents who played at least 100 snaps are poised to test the market.

The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $32.87, denoting a +0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily ...

The Minnesota Vikings saw their surprise season implode over the final two weeks of the season and playoffs, losing to the Detroit Lions in the season finale to become the 14-win wild card team in ...

Kevin O'Connell has parlayed a 14-win season into a new contact. Fresh off what was a largely successful 2024 season, the Vikings' head coach has agreed to terms on a multi-year deal with the team ...

EAGAN, Minn. -- The Minnesota Vikings and coach Kevin O'Connell agreed Tuesday on a multiyear contract extension, closing an unusual chapter and locking down one of the NFL's top young head coaches.

MINNEAPOLIS — The Vikings and coach Kevin O’Connell agreed to terms on a multiyear contract extension on Tuesday, following a 14-3 regular season that defied external widespread preseason ...

Kevin O’Connell isn’t going anywhere. The Minnesota Vikings agreed to a multi-year contract extension with O’Connell on Tuesday afternoon, the team announced. While specifics of the deal ...

The upstart, clinical stage biotech company Viking Therapeutics, Inc. (NASDAQ:VKTX), which is attempting to disrupt their market leadership has also suffered from a protracted hangover ...